Investigating the impact of helminth infection on microbioma composition and innate immunity generated during HepB vaccination.
Investigating the impact of helminth infection on microbioma composition and innate immunity generated during HepB vaccination.
批准号:
10163555
负责人:
Rafick Pierre Sekaly
金额:
$31.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-05-29 至
关键词:
Administrative SupplementBiologicalBiological AssayCOVID-19ClinicalClinical DataCohort StudiesDataDisease ProgressionGoalsImageImmune System DiseasesImmune responseImmunophenotypingInfectionIrrigationKnowledgeLaboratoriesLeadershipNatural ImmunityOhioPennsylvaniaPeripheral Blood Mononuclear CellPhenotypeReadingSamplingSpecimenSputumStandardizationTestingUniversitiesVaccinationViral PathogenesisViruscohortcoronavirus diseasehelminth infectionimmunological statusprogramssample collection
中文摘要
总结:
行政补充的目标是提供一个中央丰富的数据和标本存储
来自位于宾夕法尼亚州阅读和俄亥俄州克利夫兰的两个独立队列。的
样本和临床数据将分发给项目指定的中心核心
在那里将进行标准化的表型分析。核心的一般领导将是
由德雷克塞尔大学的Charles凯恩斯博士为阅读队列提供,
凯斯西储大学Case Western Reserve University
本行政补充规定有三个目的。
具体目标1:为我们所有的人提供生物标本(PBMC、痰液和灌洗液)
指定的核心,以表征免疫表型和免疫状态,
应对COVID-19感染。
具体目标2:为我们所有指定的患者提供临床数据(CBC计数、临床检查、成像)
核心,以建立与免疫状态和疾病进展的相关性
具体目标3:向我们指定的实验室提供生物样本和临床数据,
德雷克塞尔大学和凯斯西方大学这些实验室将进行独特的检测,
该项目的核心实验室。
英文摘要
Summary:
The goal of the Administrative Supplement is to provide a central rich store of data and specimens
from two independent cohorts located in Reading, Pennsylvania and Cleveland, Ohio. The
samples and the clinical data will be distributed to the central cores assigned by the program
where standardized phenotypic assays will be performed. General leadership of the Cores will be
provided by Dr. Charles Cairns from Drexel University for the Reading cohort and Dr. Benigno
from Case Western Reserve University.
There are 3 aims of this Administrative supplement.
Specific Aim 1: To provide biological specimens (PBMCs, sputum, and lavages) to all our
designated cores in order to characterize the immunophenotypes and the immune status and
response to COVID-19 infection.
Specific Aim 2: To provide clinical data (CBC counts, clinical tests, imaging) to all our designated
cores in order to establish correlation with immune status and disease progression
Specific Aim 3: To provide biological specimens and clinical data to our assigned laboratories at
Drexel and Case Western Universities. These laboratories will perform unique assays that are not
covered by the core laboratories of the program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MultiOMICS mechanistic identification of predictors of HIV DNA decay, restoration of immune homeostasis and HIV specific immunity in PWH with cancer receiving Immune check point therapy
-
批准号:10731665
-
项目类别:
-
资助金额:$42.08万
-
财政年份:2023
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:10588314
-
项目类别:
-
资助金额:$79.33万
-
财政年份:2023
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir
-
批准号:10731661
-
项目类别:
-
资助金额:$129.39万
-
财政年份:2023
-
负责人:Rafick Pierre Sekaly
-
依托单位:
MOIR - Administrative Core
-
批准号:10731662
-
项目类别:
-
资助金额:$9.62万
-
财政年份:2023
-
负责人:Rafick Pierre Sekaly
-
依托单位:
I2 Control= Modulating Innate Immunity to Achieve Control of HIV
-
批准号:10731664
-
项目类别:
-
资助金额:$45.37万
-
财政年份:2023
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Emory/Georgia TB Research Advancement Center (TRAC)
-
批准号:10429404
-
项目类别:
-
资助金额:$19.73万
-
财政年份:2022
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Emory/Georgia TB Research Advancement Center (TRAC)
-
批准号:10596182
-
项目类别:
-
资助金额:$8.72万
-
财政年份:2022
-
负责人:Rafick Pierre Sekaly
-
依托单位:
A multi-tiered approach to develop validated assays to predict efficacy of a tetravalent live attenuated Dengue Virus vaccine in Phase II and Phase III clinical trials
-
批准号:10341373
-
项目类别:
-
资助金额:$104.7万
-
财政年份:2021
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
-
批准号:10222321
-
项目类别:
-
资助金额:$79.55万
-
财政年份:2020
-
负责人:Rafick Pierre Sekaly
-
依托单位:
An unbiased OMICs approach to identify mechanisms of Cocaine regulation of the HIV reservoir
-
批准号:10321500
-
项目类别:
-
资助金额:$74.39万
-
财政年份:2020
-
负责人:Rafick Pierre Sekaly
-
依托单位:
OMICs to define impact of cocaine on immunity and HIV persistence in treated HIV infection
-
批准号:10321501
-
项目类别:
-
资助金额:$53.2万
-
财政年份:2020
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
-
批准号:10680632
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2020
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Core C - Modeling Core
-
批准号:10080706
-
项目类别:
-
资助金额:$41.09万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:9623814
-
项目类别:
-
资助金额:$87.52万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:10198704
-
项目类别:
-
资助金额:$154.03万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Core C - Modeling Core
-
批准号:10322684
-
项目类别:
-
资助金额:$40.56万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:9979743
-
项目类别:
-
资助金额:$63.67万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:10336870
-
项目类别:
-
资助金额:$30.85万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:10463861
-
项目类别:
-
资助金额:$76.96万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Resetting immune homeostasis: a non-invasive approach towards HIV eradication
-
批准号:10303927
-
项目类别:
-
资助金额:$134.71万
-
财政年份:2017
-
负责人:Rafick Pierre Sekaly
-
依托单位:
海外基金